Tuesday, 17 November 2026 Every SEC filing alert, by company
ALFA USA Filings Every alert, straight from SEC EDGAR
News
Financial Results · Q3 2026

BioCorRx Q3 2026 Results: Net Loss of $797K, Loss Narrows

BioCorRx Inc. reported a net loss of $2,707,744 for the nine months ended September 30, 2026, compared to a loss of $2,921,916 in the prior year period. Total revenues decreased significantly to $126,690 from $527,047, while the company continues to rely heavily on grant income, which totaled $1,810,748 for the first nine months of 2026.

Q3 2026 at a glance · $ million
MetricQ3 2026Q3 2025
Revenue-0.00.2
Profit before tax-0.8-0.8
Net income-0.8-0.8
EPS (diluted, $ a share)$-0.03$-0.05

A dash means the filing did not report that period. Growth is not shown when either period was a loss. Figures from the filing's XBRL data.

Source

10-Q filed with the SEC, OTC: BICX. Figures from the filing's XBRL data; summary written with AI assistance from the filing.

Read the filing ↗

BioCorRx Inc.: key numbers

Share price
$0.2110Close, Nov 13
Market cap
$6.47M
Shares outstanding
30.64MLatest SEC cover page
Sector
Industrial Applications and Services
Industry
Services-Specialty Outpatient Facilities, NECSIC 8093

Today's reference numbers, updated daily. Not a valuation or a recommendation.

Get Alerts

Get ALFA Finder alerts first

Real-time SEC filing alerts for US stocks are launching soon. Leave your details and we'll tell you the moment they go live.